These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24549533)

  • 21. IOM reports err regarding peer review confidentiality.
    Griffen FD
    Bull Am Coll Surg; 2003 Jan; 88(1):8-11. PubMed ID: 23581032
    [No Abstract]   [Full Text] [Related]  

  • 22. Science and government. Review for NCCAM is overdue.
    Marcus DM; Grollman AP
    Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives. IOM: NIH needs big strategy, not fewer institutes.
    Med Health; 2003 Aug; 57(29):7-8. PubMed ID: 12934435
    [No Abstract]   [Full Text] [Related]  

  • 24. Biomedical funds: IOM strikes back.
    Palca J
    Science; 1990 Dec; 250(4986):1332. PubMed ID: 2255903
    [No Abstract]   [Full Text] [Related]  

  • 25. AIDS research. IOM panel clears HIV prevention study.
    Couzin J
    Science; 2005 Apr; 308(5720):334. PubMed ID: 15831722
    [No Abstract]   [Full Text] [Related]  

  • 26. National Academies of Sciences, Engineering, and Medicine (NASEM).
    Stanos SP
    Pain Med; 2017 Oct; 18(10):1835-1836. PubMed ID: 29044411
    [No Abstract]   [Full Text] [Related]  

  • 27. Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
    Gostin LO; Altevogt BM; Pope AM
    JAMA; 2014 Feb; 311(7):671-2. PubMed ID: 24435443
    [No Abstract]   [Full Text] [Related]  

  • 28. Open access as public policy.
    Gass A
    PLoS Biol; 2004 Oct; 2(10):e353. PubMed ID: 15486586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Information access. NIH public access policy.
    Zerhouni EA
    Science; 2004 Dec; 306(5703):1895. PubMed ID: 15591188
    [No Abstract]   [Full Text] [Related]  

  • 30. The complementary and alternative medicine controversy continues: the IOM report.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(4):5-9. PubMed ID: 16431827
    [No Abstract]   [Full Text] [Related]  

  • 31. PLOS position on NIH public access policy.
    Gass A; Doyle H
    Science; 2005 Apr; 308(5720):356. PubMed ID: 15831740
    [No Abstract]   [Full Text] [Related]  

  • 32. Xenotransplantation trials 'should proceed but need guidelines'.
    Wadman M
    Nature; 1996 Jul; 382(6588):197. PubMed ID: 8717028
    [No Abstract]   [Full Text] [Related]  

  • 33. Panel clears NIH in patient deaths.
    Stone R
    Science; 1995 Mar; 267(5205):1759. PubMed ID: 7892593
    [No Abstract]   [Full Text] [Related]  

  • 34. IOM advises FDA on ethics in postmarket safety trials.
    Kuehn BM
    JAMA; 2010 Aug; 304(6):627. PubMed ID: 20699450
    [No Abstract]   [Full Text] [Related]  

  • 35. IOM report: patient safety--achieving a new standard for care.
    Institute of Medicine
    Acad Emerg Med; 2005 Oct; 12(10):1011-2. PubMed ID: 16204148
    [No Abstract]   [Full Text] [Related]  

  • 36. Support for the NIH public access policy.
    Rogawski MA; Suber P
    Science; 2006 Sep; 313(5793):1572. PubMed ID: 16973859
    [No Abstract]   [Full Text] [Related]  

  • 37. IOM report calls for a more streamlined, faster cancer cooperative trials program.
    Kuehn BM
    JAMA; 2010 Jun; 303(21):2126-7. PubMed ID: 20516407
    [No Abstract]   [Full Text] [Related]  

  • 38. Biodefense. U.S. agencies unveil plan for biosecurity peer review.
    Couzin J
    Science; 2004 Mar; 303(5664):1595. PubMed ID: 15016970
    [No Abstract]   [Full Text] [Related]  

  • 39. NIH seeks input on data sharing policies.
    Physiologist; 2007 Feb; 50(1):22-3. PubMed ID: 17366942
    [No Abstract]   [Full Text] [Related]  

  • 40. Public access failure at PubMed.
    Stebbins M; Davis E; Royland L; White G
    Science; 2006 Jul; 313(5783):43. PubMed ID: 16825550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.